2018 AANS Annual Scientific Meeting-The International Initiative for Traumatic Brain Injury Research (InTBIR)

The International Initiative for Traumatic Brain Injury Research (InTBIR)

Video Transcription

Video Summary

Dr. Jeff Manley, a professor of neurosurgery at the University of California San Francisco, gives a concluding talk on international initiatives regarding traumatic brain injury (TBI) research. He highlights the importance of standardized data collection and structured imaging, such as MRI scans, in understanding TBI. Dr. Manley emphasizes the significance of blood-based biomarkers, particularly GFAP and UCHL1, in diagnosing and managing TBI. GFAP and UCHL1 have been approved by the Food and Drug Administration, making them the first approved blood-based biomarkers for TBI. Dr. Manley discusses the potential of a handheld point-of-care device to measure these biomarkers, enhancing the screening and diagnosis of TBI patients. He concludes by emphasizing the importance of international collaboration in TBI research, as seen in initiatives like Center-TBI and Track-TBI, to drive advances in diagnosis and treatment. (Word count: 195)

Asset Caption

Geoffrey T. Manley, MD, PhD, FAANS

Keywords

traumatic brain injury

GFAP

UCHL1

diagnosis

MRI scans

international collaboration